Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer Inc

2 Stocks That Have Wall Street's Stamp of Approval

Despite rampant market volatility ahead of the November jobs data, and possible recession fears, experts believe the U.S. economy is resilient enough to handle a potential growth slowdown. Given the possibility of a year-end rally, quality stocks Pfizer (PFE) and AT&T (T) could now be ideal additions to your portfolio.…

StockNews.com

3 Stocks That Still Have Room to Run

With the October inflation report showing signs of cooling and anticipations of a slowdown in interest rate hikes, the stock market looks poised to extend its recent rally. Hence, it could be wise to invest in fundamentally sound stocks Pfizer (PFE), Cisco Systems (CSCO), and Raytheon Technologies (RTX) that still…

StockNews.com

1 High-Dividend Stock to Add to Your Portfolio if You Haven’t Already

Amid prevalent COVID-19 cases, vaccine pioneer Pfizer (PFE) is significantly benefiting. Moreover, the company beat wall street expectations in the third quarter with a robust financial result and raised its revenue and EPS guidance for the year. Given its strong fundamentals, the stock could be a wise addition to your…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharmaceutical Stocks to Invest in This Month

The pharmaceutical industry is rapidly evolving to meet today’s health challenges. The pharmaceutical industry's long-term prospects look bright with a globally aging population set to increase healthcare expenditure. Moreover, given the industry’s ability to stay resilient amid economic headwinds, it could be wise to invest in fundamentally strong pharmaceutical stocks…

StockNews.com

3 Strong Buy Stocks to Continue to Hold Onto in 2023

As the Fed’s aggressive monetary policy resulted in slightly cooled inflation last month, investors are hopeful of smaller rate hikes ahead. However, since a recession is expected to hit the economy next year, we think fundamentally sound stocks Pfizer (PFE), Flowers Foods (FLO), and Xperi (XPER), which are rated Strong…

StockNews.com

2 Strong Stocks to Consider Buying This November

While market volatility is still prevalent, experts believe the U.S. economy might succeed in achieving a 'soft landing.' Moreover, most S&P 500 companies surpassed revenue and EPS estimates in the third quarter. Therefore, fundamentally sound stocks Pfizer (PFE) and Flowers Foods (FLO) could be ideal additions to your portfolio now.…

StockNews.com

Pfizer/BioNTech's updated COVID shot shows strong response against BQ.1.1

Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot produced higher virus-neutralizing antibodies in older adults against the emerging subvariant BQ.1.1 than its original vaccine.

Reuters

Read news from The Economist, FT, and more,
with one subscription

3 Dividend Stocks to Buy to Help Soothe Some of Your Pain

Although inflation eased slightly last month, the Fed has indicated that the final level of interest rates could be higher than expected. With further interest rate hikes and the possibility of a recession expected to keep the market under pressure, it could be wise to buy dividend-paying stocks Pfizer (PFE),…

StockNews.com

Could Pfizer Stock Help You Retire a Millionaire?

Leading biopharmaceutical company Pfizer’s (PFE) third-quarter results demonstrated strength across most areas of its business. Moreover, the company raised its 2022 financial guidance for revenues and adjusted EPS. Also, the company has increased its dividend for 12 consecutive years, and its annual dividend yields more than 3%. Given its solid…

StockNews.com

3 Stocks Wall Street Loves

Amid the ongoing macroeconomic and geopolitical issues, the stock market has faced wild swings this year. As the sky-high inflation and the Fed’s aggressive rate hikes continue to heighten recessionary fears, Wall Street darlings Microsoft (MSFT), Pfizer (PFE), and Coca-Cola (KO), which have a solid dividend-paying record, might be ideal…

StockNews.com

European regulator recommends Pfizer's Omicron booster for children

Pfizer Inc and its partner BioNTech said on Thursday the EU health regulator has recommended authorising the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.

Reuters

2 Stocks to Help You Beat the Bear Market Blues

The Fed’s aggressive rate hikes to tame the stubborn inflation have led to widespread recession fears. The stock market has witnessed a significant selloff. Moreover, as the bear market seems not over yet, we think fundamentally strong dividend-paying stocks, Pfizer (PFE) and Kroger (KR), might help you beat the bear…

StockNews.com

3 Strong Stocks to Buy Before the Next Bull Market

The economy is showing resilience despite the Fed’s aggressive rate hikes. Moreover, Goldman Sachs’ top economist believes the economy might succeed in avoiding a recession. We think investors could buy fundamentally sound stocks Pfizer (PFE), Cisco Systems (CSCO), and United Parcel (UPS) before the next bull market. Read on….

StockNews.com

2 Stocks to Buy if You're Looking to Make Passive Income

Despite rampant macro headwinds, job growth in October surpassed estimates. Moreover, President Joe Biden remains confident that the country's economy will rebound shortly. Investors looking to make passive income could now add quality dividend stocks Pfizer (PFE) and PepsiCo (PEP) to their portfolios. Keep reading….

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Pfizer’s Paxlovid antiviral drug lowered risk of long COVID symptoms in study

Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some symptoms of disabling long COVID, a study found.

StockNews.com

2 Stocks You Can Count on for Reliable Dividends

The Fed announced its fourth consecutive 75-bps rate hike this week. However, the Fed's aggression is expected to shrink eventually. Amid rampant market volatility, investor sentiment toward dividend stocks is robust. Therefore, fundamentally sound stocks Pfizer (PFE) and Caledonia Mining (CMCL) could be solid picks for a steady income stream.…

Reuters

Pfizer, BioNTech start COVID-flu combination vaccine study

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.

StockNews.com

These 3 Stocks Are a Must When Building Your Dividend Portfolio

Since the uncertain economic conditions are expected to keep the stock market under pressure, dividend-paying stocks Pfizer (PFE), ICL Group (ICL), and ARC Document Solutions (ARC) could be solid additions to your portfolio for generating a steady income stream. Keep reading….

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Here Are 3 Stocks to Buy Under $50 in Q4

Although the stock market has been under pressure this year, many believe bulls will overtake the bears in 2023. Moreover, the U.S. economy’s third-quarter GDP surpassed growth estimates, easing recession fears to some extent. Therefore, this could be the right time to scoop up quality stocks Pfizer (PFE), Ryerson Holding…

StockNews.com

3 Stocks That Are Great for Passive Income Investors

Though the U.S. economy bounced back after shrinking in the first half of the year, falling consumer spending and the rate hikes to tame high inflation might lead the economy into a recession. Hence, investors looking for passive income could invest in fundamentally sound dividend-paying stocks Pfizer (PFE), Sanofi (SNY),…

StockNews.com

2 Health Care Stocks You Can Always Count On

With inflation showing no signs of slowing down, the chances of another 75-bps rate hike are increasing. Investing in healthcare stocks tends to help investors hedge against economic downturns. And given the sound prospects of the healthcare sector, fundamentally sound healthcare stocks Pfizer (PFE) and Humana (HUM) could be good…

StockNews.com

3 Recession-Proof Stocks to Buy in October

Various headwinds, including the widespread fears of a recession, have kept the market clenched in a bear grip. Amid this backdrop, resilient stocks Pfizer (PFE), Waste Management (WM), and Ingles Markets (IMKTA), which belong to essential sectors and possess inelastic demand for their products or services, could be appropriate additions…

StockNews.com

4 Income Stocks You Could Buy and Hold Forever

As the central banks worldwide are determined to battle sky-high inflation with big rate hikes, top economists warn of a global recession on the way. While volatility is rife in the stock market, reliable dividend-paying stocks Pfizer (PFE), McKesson (MCK), Nutrien (NTR), and Genie Energy (GNE) might be ideal investments…

StockNews.com

This Pharmaceutical Stock Is Still a Smart Buy in 2022

Pfizer’s (PFE) co-developed COVID-19 vaccine booster for children, which recently got Emergency Use Authorization from the U.S. FDA, could boost its share price. The stock had witnessed significant attention during the pandemic and could still be worth owning. Let’s discuss this in detail….

StockNews.com

2 Stocks Under $50 You Shouldn’t Ignore in Q4

Sky-rocketing inflation and the Fed’s hawkish tilt have led to an economic slowdown. However, a decent start to the corporate earnings season is lifting investors’ optimism. And we think it will not be wise for investors to ignore fundamentally solid stocks such as Pfizer (PFE) and Kroger (KR), currently trading…

1 … 5 6 7 8

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.